Why CVS Health Corp. (CVS) stock moved
CVS Health Corp. (CVS) shares rose 3.1% to $83.85 as of November 7, 2026, a moderate gain from the prior close of $81.33. BestStocks flagged the session as a major change for CVS. Below, we break down what changed for CVS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CVS climbed 3.1% to $83.85
CVS rose 3.1% in its latest session, moving from $81.33 to $83.85.
What it means for CVS Health Corp. investors
For CVS Health Corp. investors, the balance of recent signals points to a bullish shift. On the constructive side: Earnings beat with positive market reaction; Positive 3.1% session move. Weighing against that: CVS Health fell 11.46% to $80.93 despite beating Q3 earnings and revenue estimates (Zacks), raising its full-year forecast on health-care benefits and pharmacy gains (Wall Street Journal), and announcing plans to split into two companies (MarketWatch); CVS Health fell 2.17% to $93.59 as investors absorbed disappointing preliminary 2027 profit guidance released last week, alongside ongoing regulatory scrutiny over its vertically integrated business model and persistent pressures in its pharmacy benefit manager segment. Because the move outpaced peers, it looks driven by CVS-specific developments rather than a broad sector rotation. Wall Street's consensus price target sits at $110.94, implying +32.3% upside from $83.85. BestStocks rates the overall signal quality medium (64/100). With earnings roughly 94 days out, the next report is the most likely near-term test of the move.
CVS price reaction
CVS last traded at $83.85, up $2.52 (+3.10%) from the previous close of $81.33. The session traded on 1.6× average volume (above avg), so the move carried above-average conviction. Its healthcare peer group moved a median -0.2% over the same stretch, leaving CVS ahead of the group by 3.3 points.
Bullish and bearish analyst opinions on CVS Health Corp. (CVS)
The consensus analyst price target on CVS Health Corp. (CVS) is $110.94, 32.3% above the recent $83.85. Over the past 90 days analysts logged 0 upgrades, 7 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CVS line up.
The bullish case
- Wall Street's consensus price target of $110.94 implies +32.3% upside from $83.85.
- The Street's most bullish target is $123.00 (+46.7%).
- Earnings beat with positive market reaction.
- Positive 3.1% session move.
- Positive price momentum.
The bearish case
- CVS Health fell 11.46% to $80.93 despite beating Q3 earnings and revenue estimates (Zacks), raising its full-year forecast on health-care benefits and pharmacy gains (Wall Street Journal), and announcing plans to split into two companies (MarketWatch).
- CVS Health fell 2.17% to $93.59 as investors absorbed disappointing preliminary 2027 profit guidance released last week, alongside ongoing regulatory scrutiny over its vertically integrated business model and persistent pressures in its pharmacy benefit manager segment.
- CVS Health Corp. moved -5.27% intraday from $104.42 to $98.92.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 7, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CVS
Frequently asked questions about CVS
Why did CVS Health Corp. (CVS) stock move?
CVS rose 3.1% to $83.85. No single company-specific catalyst was confirmed during the move window, and it looks like a company-specific move.
How much did CVS stock rise?
CVS gained 3.10% ($2.52) versus the prior close of $81.33, last trading at $83.85 on 1.6× average volume.
When is CVS Health Corp.'s next earnings date?
CVS's next earnings report is estimated for 2027-02-09 — about 94 days away.
What is the analyst price target for CVS?
The consensus analyst price target for CVS is $110.94, about 32.3% above the current $83.85. Over the past 90 days, analysts recorded 0 upgrades, 7 maintains, and 0 downgrades.
Is the CVS move company-specific or sector-wide?
BestStocks classifies it as a company-specific move: the peer group moved a median -0.2% against CVS's +3.1%. CVS ranks top 1 of 7 peers.
How BestStocks tracks CVS
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared CVS-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for CVS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 7, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.